Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/12/1996WO1996039144A1 Stable copper(i) complexes as active therapeutic substances
12/12/1996WO1996039143A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039141A1 Methods for minimizing bone loss
12/12/1996WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/12/1996WO1996039139A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/12/1996WO1996039138A1 Methods for minimizing bone loss
12/12/1996WO1996039136A1 Transdermal formulation comprising ropinirole
12/12/1996WO1996039135A1 Methods of inhibiting melanoma
12/12/1996WO1996039134A1 Osteogenetic promoting pharmaceutical composition
12/12/1996WO1996039131A1 Topical composition for fungal treatment
12/12/1996WO1996039129A1 Methods of increasing amyloid deposition
12/12/1996WO1996039128A1 Protein particles for therapeutic and diagnostic use
12/12/1996WO1996039126A2 Ranitidine salts on magnesium trisilicate as an adsorbate
12/12/1996WO1996039123A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating
12/12/1996WO1996039121A1 Submicron liposome suspensions obtained from preliposome lyophilizates
12/12/1996WO1996039119A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996WO1996039035A1 Myogenic differentiation of human mesenchymal stem cells
12/12/1996WO1996039033A1 Betulinic acid derivatives and uses therefor
12/12/1996WO1996031206A3 Flavones and coumarins as agents for the treatment of atherosclerosis
12/12/1996WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
12/12/1996WO1996020187A3 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
12/12/1996WO1996019458A3 Steroid receptor modulator compounds and methods
12/12/1996DE19521932A1 Treatment for pesticide poisoning
12/12/1996DE19521240A1 Combination of halogenated (poly)nitrile and phenyl alcohol
12/12/1996DE19520936A1 Ektoparasitizide Mittel Ectoparasiticidal means
12/12/1996DE19520792A1 Use of nitric oxide synthase inhibitors to inhibit nasal swelling
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223874A1 Methods and compositions for inhibiting cytomegalovirus replication
12/12/1996CA2223585A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223400A1 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
12/12/1996CA2223393A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/12/1996CA2223388A1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
12/12/1996CA2223383A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223239A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
12/12/1996CA2223174A1 Methods for minimizing bone loss
12/12/1996CA2223157A1 Methods of inhibiting melanoma
12/12/1996CA2223108A1 Topical composition for fungal treatment
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2223055A1 Methods for minimizing bone loss
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222950A1 Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating
12/12/1996CA2222915A1 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
12/12/1996CA2222331A1 Heterocyclic methyl free radicals as image enhancing agents
12/12/1996CA2222322A1 Quinolizinone type compounds
12/12/1996CA2222040A1 Macrophage lipid chemoattractant
12/12/1996CA2221844A1 Disodium alendronate formulations
12/12/1996CA2221842A1 Alpha 1a adrenergic receptor antagonists
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221784A1 Osteogenetic promoting pharmaceutical composition
12/12/1996CA2221684A1 Novel cathepsin and methods and compositions for inhibition thereof
12/12/1996CA2221416A1 Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
12/12/1996CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996CA2220895A1 Protein particles for therapeutic and diagnostic use
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2219447A1 Methods of increasing amyloid deposition
12/12/1996CA2218531A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
12/12/1996CA2217229A1 Pineal gland specific gene-1
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2210291A1 Treatment of cholera
12/12/1996CA2210227A1 Treatment of cholera
12/12/1996CA2210202A1 Treatment of traveller's diarrhea
12/12/1996CA2210193A1 Treatment of traveller's diarrhea
12/11/1996EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
12/11/1996EP0747395A1 Composition for treating renal failure
12/11/1996EP0747393A1 Thiazolo benzazepine containing dual action inhibitors
12/11/1996EP0747392A1 1,2-Diazepine containing dual action inhibitors
12/11/1996EP0747389A1 3'-substituted nucleoside derivatives
12/11/1996EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation
12/11/1996EP0747385A1 Prodrugs of paclitaxel derivatives
12/11/1996EP0747383A2 Polyamine salts of clavulanic acid
12/11/1996EP0747381A1 Carbapenem derivative
12/11/1996EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747379A1 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia
12/11/1996EP0747378A1 Dihydropyridine NPY antagonists
12/11/1996EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains
12/11/1996EP0747374A1 Sulfonamido substituted benzopyran potassium channel activators
12/11/1996EP0747368A1 Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents
12/11/1996EP0747363A1 Anti-viral benzimidazole derivatives
12/11/1996EP0747357A2 Dihydropyridine NPY antagonists: piperidine derivatives
12/11/1996EP0747356A1 Dihydropyridine NPY antagonists: piperazine derivatives
12/11/1996EP0747354A1 3-Substituted oxindole derivatives as potassium channel modulators
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/11/1996EP0747347A1 RARy-specific retinobenzoic acid derivatives
12/11/1996EP0747346A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
12/11/1996EP0747345A2 Ethylamido fluorenes and improved method of making same
12/11/1996EP0747061A2 Controlled release inclusion system of glycolic acid in beta-cyclo-dextrin and process for the above system preparation
12/11/1996EP0747056A2 Methods for minimizing bone loss
12/11/1996EP0747055A2 Use of tachykinin receptors antagonists for the treatment of cold and allergic rhinitis
12/11/1996EP0747054A2 Methods for minimizing bone loss
12/11/1996EP0747053A2 Methods of inhibiting melanoma
12/11/1996EP0747052A2 Methods of modulating NF-KB transcription factor
12/11/1996EP0747051A2 Methods of inducing BEF-1 transcription factor
12/11/1996EP0747050A1 Pharmaceutical compositions containing irbesartan
12/11/1996EP0747048A2 Diterpenes and flavonoids as 5-alpha-reductase inhibitors
1 ... 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 ... 7860